Timothy Pigot - CHIEF COMMERCIAL OFFICER at Jade Biosciences, Inc.

Issuer-level insider activity

Role
Chief Commercial Officer
Issuer ticker
JBIO on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Timothy Pigot since 21 Oct 2025

Reported holdings for Timothy Pigot in Jade Biosciences, Inc.

Form 4 holding CHIEF COMMERCIAL OFFICER

Aerovate Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
66,586
Estimated value
$898,245
Report date
22 Jan 2024
Price
$13.49
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF COMMERCIAL OFFICER

Aerovate Therapeutics, Inc.

Security class
Common Stock
Shares / value
1,291
Estimated value
$25,175
Report date
22 Jan 2024
Price
$19.50
Ownership
Direct

Transaction history for Timothy Pigot in Jade Biosciences, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .